Chronic care market Oxitone targets high-cost chronic care management with continuous remote monitoring, presenting a compelling value proposition for payers, hospitals, and chronic disease programs seeking to reduce costly interventions.

FDA certified sensor The 1000M wrist monitor with ULNAR BONE FlexSense technology is FDA-cleared and CE-certified, offering a differentiated, comfortable, non-invasive alternative to fingertip probes, which can ease clinical adoption and increase clinician trust.

AI driven VitalsTone AI analytics engine provides real-time, hospital-grade parametric analytics to guide personalized therapy, creating upsell opportunities for integration with clinical decision support systems and remote patient monitoring bundles.

Wearable ecosystem Integrated wearables technology and digital health capabilities position Oxitone to partner with hospitals, home health providers, and telehealth platforms seeking scalable remote monitoring solutions for complex conditions.

Growth potential Current revenue and funding levels suggest a small but scalable solution with opportunities to expand into mid-market and enterprise accounts, leveraging existing clinical validations and media recognition to accelerate sales pipelines.